Cargando…
COVID-19 vaccines: breaking record times to first-in-human trials
The twenty-first century has come with a new era in vaccinology, in which recombinant genetic technology has contributed to setting an unprecedented fast pace in vaccine development, clearly demonstrated during the recent COVID-19 pandemic.
Autores principales: | Kim, Young Chan, Dema, Barbara, Reyes-Sandoval, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193619/ https://www.ncbi.nlm.nih.gov/pubmed/32377399 http://dx.doi.org/10.1038/s41541-020-0188-3 |
Ejemplares similares
-
First clinical trial of a MERS coronavirus DNA vaccine
por: Yoon, In-Kyu, et al.
Publicado: (2019) -
First human efficacy study of a plant-derived influenza vaccine
por: Tregoning, John S
Publicado: (2020) -
Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021) -
Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
por: Modjarrad, Kayvon, et al.
Publicado: (2020) -
Pharmacological trials for long COVID: first light at the end of the tunnel
por: Buonsenso, Danilo
Publicado: (2022)